These data were corroborated by a recent study that showed the effect of myricetin, a phenolic compound, modulating lung inflammation in an ALI model by inhibiting NF-κB activation and inflammatory cytokine production [27]. Here, NFKB1 is linked to acute respiratory distress syndrome.